Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose Primaquine for P. falciparum Gametocyte Clearance
NCT02090036Phase 4Completed
- Sponsor
- Muhimbili University of Health and Allied Sciences
- Start
- Jul 2014
- Primary completion
- Oct 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of primaquine in Plasmodium falciparum malaria, sponsored by Muhimbili University of Health and Allied Sciences. Started Jul 2014; status: completed.
02
Drugs
primaquine
03
Conditions
Plasmodium falciparum malaria
Beyond the preview
Go deeper on NCT02090036.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02090036.